A recently generated transgenic mouse line having activated polyamine catabolism due to systemic overexpression of spermidine/spermine N 1 -acetyltransferase (SSAT) was used to isolate primary fetal fibroblasts as a means to further elucidate the cellular consequences of activated polyamine catabolism. Basal levels of SSAT activity and steady-state mRNA in the transgenic fibroblasts were about ϳ20-and ϳ40-fold higher than in nontransgenic fibroblasts. Consistent with activated polyamine catabolism, there was an overaccumulation of putrescine and N 1 -acetylspermidine and a decrease in spermidine and spermine pools. Treatment with the polyamine analogue N 1 ,N 11 -diethylnorspermine (DENSPM) increased SSAT activity in the transgenic fibroblasts ϳ380-fold, whereas mRNA increased only ϳ3-fold, indicating post-mRNA regulation. SSAT activity in the nontransgenic fibroblasts increased ϳ200-fold. By Western blot, enzyme protein was found to increase ϳ46 times higher in the treated transgenic fibroblasts than non-transgenic fibroblasts: a value comparable to 36-fold differential in enzyme activity. With DENSPM treatment, spermidine pools were more rapidly depleted in the transgenic fibroblasts than in nontransgenic fibroblasts. Similarly, transgenic fibroblasts were much more sensitive to DENSPM-induced growth inhibition. This was not diminished by co-treatment with an inhibitor of polyamine oxidase, suggesting that growth inhibition was due to polyamine depletion per se as opposed to oxidative stress. Since the two fibroblasts were genetically identical except for the transgene, the various metabolic and growth response differences are directly attributable to overexpression of SSAT.Deregulated polyamine biosynthesis as indicated by overexpressed ornithine decarboxylase (ODC) 1 activity is a well recognized characteristic of animal and human cancers. In at least one tumor type, the genetic basis for this has been attributed to a point mutation leading to stabilization of the enzyme protein (1). Although several groups have reported that ODC may play a causative role in the process of cell transformation in cultured systems (2)(3)(4), that function appears to be attenuated in vivo. Transgenic mice that systemically overexpress native ODC by at least 20-fold fail to show an increased incidence of tumors in any of their tissues (5). More likely, the enzyme interacts with other genes to fulfill a facilitating role in tumorigenesis not unlike that seen with oncogene cooperativity, a phenomenon that has been previously demonstrated between ODC and ras (6). This potential is clearly indicated in mouse skin carcinogenesis models where induction of ODC activity represents an early response to tumor promoters (7) and is known to be critical to tumor formation (8, 9). In this regard, O'Brien's group (10) recently reported that transgenic mice that overexpress a stabilized form of ODC in the skin are much more susceptible to 7,12-dimethylbenz(a)anthracene-induced carcinogenesis. In addition, their findings strongly suggest that am...